National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

oblimersen sodium
The sodium salt of a phosphorothioate antisense oligonucleotide targeted to the initiation codon region of mRNA for the anti-apoptotic gene Bcl-2. Oblimersen inhibits Bcl-2 mRNA translation, which may result in decreased expression of the Bcl-2 protein and tumor cell apoptosis. This agent may enhance the efficacy of standard cytotoxic chemotherapy. The anti-apoptotic bcl-2 protein is an integral outer mitochondrial membrane protein (OMMP) that is overexpressed in some cancer cell types and is linked to tumor drug resistance. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:augmerosen
G3139 bcl-2 antisense oligodeoxynucleotide
US brand name:Genasense
Code name:G3139



Previous:NY-ESO-1/LAGE-1 HLA class I/II peptide vaccine, NY-ESO-1b peptide vaccine, NY-ESO-B, O6-benzylguanine, obatoclax mesylate
Next:octreotide acetate, octreotide pamoate, odanacatib, Oestrogenine, Oestromenin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov